Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Beckman, Emmecell, Genmab, Movmedix, Organogenesis, Revolution, Saol.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alamar, Alcon, Bio-Rad, Biocartis, Biocytogen, Cresilon, Corza, Discovery, Ethos, GTCR, Incite Genomics, Novo Nordisk, Praxis, Remagine, Rxsight, Vivani, Whitehawk, Xeltis.

Clinical updates for biopharma and med tech, including data readouts and publications: Compass, HMNC, Italfarmaco, ITM, Kailera, Oncotelic, Teva, Turn, Tvardi, Vaxart, Volitionrx.

Biopharma and med-tech companies raising money in public or private financings, including: Fore, Healome, Kalohexis, Semnur.

New hires and promotions in the biopharma and med-tech industries, including: Akari, Amplia, Biovica, Demerx, Eupraxia, Imagenebio, Jupiter, Kymera, Levicept, Longeveron, Paradromics, Stipple, Uniquity, Vascular Perfusion Solutions.

BioWorld briefs for July 8, 2026.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Ascelia, Forus, Invivyd, Median, Pharmaessentia, Pharvaris, Visby.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Astex, Baiyunshan, Genentech, Incyte, Natera, Roche, Sanyou, Star, Tempramed, Vega.

Clinical updates for biopharma and med tech, including data readouts and publications: Agenus, Anixa, Brii.

Biopharma and med-tech companies raising money in public or private financings, including: Scribe.